Hospital program shields vulnerable liver patients from dangerous painkillers
NCT ID NCT07249294
Summary
This study tests a hospital-wide program designed to stop doctors from prescribing common pain medications like ibuprofen or metamizole to patients with advanced liver disease who are having major surgery. These drugs can cause serious kidney problems, fluid buildup, or bleeding in these vulnerable patients. The program uses computer alerts, updated guidelines, and team coordination to ensure safer pain management.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for PORTAL HYPERTENSION RELATED TO CIRRHOSIS are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Hospital del Mar
Barcelona, 08003, Spain
Conditions
Explore the condition pages connected to this study.